Industry › BioTech

Press Releases

Eisai Inc. Collaborates with C2N to Build Awareness and Real-World Evidence for Blood-based Assays

Aug 24, 2022 15:18 HKT/SGT

米国子会社エーザイ・インクが米国の実臨床において認知機能障害当事者様に対する血液検査法の活用について、認知度向上とリアルワールド・エビデンス構築に向けてC2N Diagnostics社と協働

Aug 24, 2022 13:00 JST

Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore

Aug 24, 2022 09:00 JST

中国抗体宣布SN1011针对视神经脊髓炎谱系疾病的新药研究申请获国家药监局批准

Aug 24, 2022 08:07 HKT/SGT

中國抗體宣佈SN1011針對視神經脊髓炎譜系疾病的新藥研究申請獲國家藥監局批准

Aug 24, 2022 08:06 HKT/SGT

Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA

Aug 24, 2022 08:05 HKT/SGT

Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore

Aug 24, 2022 07:55 HKT/SGT

Oculis公佈II期數據抗腫瘤壞死因子(anti-TNFa)眼藥滴劑利卡明利單抗(OCS-02)可緩解嚴重干眼病患者的持續眼部不適

Aug 23, 2022 20:38 HKT/SGT

Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease

Aug 23, 2022 20:37 HKT/SGT

中国生物制药（1177.HK）公布2022年中期业绩，收入上升5.9%至人民币151.94亿元

Aug 23, 2022 19:53 HKT/SGT

中國生物製藥（1177.HK）公布2022年中期業績，收入上升5.9%至人民幣151.94億元

Aug 23, 2022 19:52 HKT/SGT

Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion

Aug 23, 2022 19:51 HKT/SGT

沛嘉医疗公布2022年中期业绩：TaurusOne(R)及TaurusElite(R)屡创月度植入量新高

Aug 22, 2022 09:31 HKT/SGT

沛嘉醫療公佈2022年中期業績：TaurusOne®及TaurusElite®屢創月度植入量新高

Aug 22, 2022 09:30 HKT/SGT

Peijia Medical Announces 2022 Interim Results: TaurusOne(R) and TaurusElite(R) Repeatedly Sets New Monthly Highs in Implantation Volume

Aug 22, 2022 09:29 HKT/SGT

华检医疗控股公布二零二二年中期业绩

Aug 22, 2022 07:32 HKT/SGT

華檢醫療控股公佈二零二二年中期業績

Aug 22, 2022 07:31 HKT/SGT

IVD Medical Announces 2022 Interim Results

Aug 22, 2022 07:30 HKT/SGT

复锐医疗科技公布2022中期业绩

Aug 20, 2022 08:52 HKT/SGT

復銳醫療科技公佈2022中期業績

Aug 20, 2022 08:51 HKT/SGT